A Phase 1/Phase 2 Clinical Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants with Hematologic Malignancies

Project: Research

StatusActive
Effective start/end date6/11/195/11/24

Keywords

  • Clinical trial
  • phase 1 and 2 study
  • treatment efficacy
  • haematological malignancy